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Abstract
Background: Hand, foot, and mouth disease (HFMD) caused by enterovirus 71 (EV71) is a potentially life-threatening
infectious disease that commonly occurs in children. Diagnosis of HFMD caused by EV71 largely depends on clinical
manifestations and rare serological biomarkers used to identify children suffering from HFMD. Serum cholinesterase
(SChE) activity has frequently been reported as a potential biomarker for solid central nervous system tumors, chronic
heart failure, and liver cirrhosis. However, its potential value in the diagnosis of neurotropic virus infections, such as
HFMD caused by EV71, remains to be determined.
Findings: In our study, 220 children hospitalized with HFMD caused by EV71, 34 inpatients infected with coxsackievirus
A16 (CVA16), and 43 undefined enterovirus-infected HFMD inpatients were recruited at the Anhui Provincial Children’s
Hospital between January 2011 and December 2012. SChE activity was measured. The non-parametric Mann–Whitney
U test showed that SChE activity in children diagnosed with HFMD caused by EV71 was significantly higher than in
healthy controls (p < 0.001), as well as in children with upper respiratory tract infections (p = 0.011), bronchopneumonia
(p < 0.001), septicemia (p < 0.001), amygdalitis (p < 0.001), and appendicitis (p < 0.001). In addition, higher SChE activity
was observed in male inpatients with HFMD caused by EV71 (47.7 % positivity) compared to female inpatients (26.1 %
positivity) (chi-square test, p = 0.002). In our study, no significant differences in SChE levels were observed
among different ages (up to 120 months) (r = -0.112, p > 0.05). An important finding was that SChE activity
declined in the recovery phase of HFMD caused by EV71 compared to the acute phase (p < 0.001).
Conclusions: Elevated SChE activity was observed in patients with severe HFMD caused by EV71. Therefore,
SChE might be a potential assistant biomarker for the diagnosis of HFMD caused by EV71 in children.
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Findings
Hand, foot, and mouth disease (HFMD) is a potentially
life-threatening infectious disease commonly found in
children. In China, 1,828,377 HFMD cases were diag-
nosed in 2013; among these, 252 cases resulted in
death, according to the report from the national Health
and Family Commission of China [1]. The main patho-
gens of HFMD are enteroviruses. In recent years, most
cases of HFMD in mainland China were caused by en-
terovirus 71 (EV71) [2–4], followed by coxsackievirus
A16 (CVA16), as well as other enterovirus serotypes.
The diagnosis of HFMD caused by EV71 largely de-
pends on the former’s clinical manifestations, such as
fever; vesicular rashes on palms, soles, and mouth; and,
in severe cases, central nervous system (CNS) involve-
ment [3, 5, 6]. Certain serological biomarkers are help-
ful for early diagnosis, timely surveillance, and
appropriate medical treatment of HFMD, in order to
avoid disease progression and death. Although some re-
ports indicate that serum levels of cytokines, such as
IL-2, IL-4, IL-10, IFN-γ, GM-CSF, and TNF-α, may be
independent risk factors for early medical intervention
[7, 8], at present there are no reliable and easily-
operated biomarkers that could be used to assist diag-
nosis of HFMD in clinical practice.
Serum cholinesterase (SChE) is an enzyme synthe-
sized by the liver. It has been reported that the en-
zyme’s activity changes under certain disease conditions
such as liver malfunction, obesity, diabetes, inflamma-
tion, and leptospiral infection [9, 10]. Serum cholin-
esterase is a routine parameter included in biochemical
panels in clinical laboratory settings. Therefore, it could
serve as a potential biomarker for clinical diagnosis. To
date, characteristics of SChE activity have not been re-
ported in HFMD, and its potential diagnostic value for
HFMD is also unclear. Therefore in this study, we mea-
sured SChE activity in HFMD patients and evaluated
its potential diagnostic value.
A total of 220 children hospitalized with HFMD
caused by EV71, 34 inpatients infected with CVA16, and
43 inpatients infected with pan-enteroviruses (members
of the enterovirus genus, PE) were recruited at the
Anhui Provincial Children’s Hospital between January
2011 and December 2012. All patients were aged one
month to 10 years and exhibited complications, with
varying degrees of CNS involvement, that caused symp-
toms such as myoclonus, ataxia, nystagmus, oculomotor
palsies, and bulbar palsy in various combinations; and/or
respiratory distress with tachycardia, tachypnea, and
rales, with or without frothy sputum. All HFMD cases
were diagnosed according to China’s Ministry of Health
guidelines [11]. Patient demographics, clinical symp-
toms, and major complications were collected retro-
spectively from the patients’ medical histories. Whole
blood samples from all participants were collected and
used for routine blood testing and in serum biochemical
parameter tests. Stool specimens were collected from
children diagnosed with HFMD and kept at -80 °C until
examined for the presence of enteroviruses by reverse
transcription polymerase chain reaction (RT-PCR). Viral
RNA was extracted from the supernatant of 10 % (V/V)
stool specimens using the QIAamp Viral RNA Mini Kit
(Qiagen, Hilden, Germany) and subjected to RT-PCR ac-
cording to the manufacturer’s instructions (DAAN Gene,
Guangzhou, China) [12–14]. The RT-PCR kit specifically
detected PE, EV71, and CVA16. The classification of
EV71, CVA16, and PE depended on the analysis of real-
time data. In addition, a total of 155 age-matched
HFMD-negative inpatient children diagnosed with upper
respiratory tract infections (URTIs) (n = 11), broncho-
pneumonia (BP) (n = 43), septicemia (n = 27), amygdalitis
(n = 7), and appendicitis (n = 18), as well as 80 age-
matched healthy children, were used as controls. The
study was approved by the institutional review board at
Peking University Health Science Center and the Anhui
Provincial Children’s Hospital. Because the specimens
were collected during the normal course of patient care,
no informed consent was required, according to the
Ethics Committee.
Serum samples were collected from clotted blood and
detection of serum biochemical parameters was carried
out within two hours of sample separation. Serum cho-
linesterase activity was determined using an assay, with
butyrylthiocholine as the substrate. The analyses were
done using Leadman reagent kits (Leadman, Beijing,
China) on a Hitachi 7600 Automatic Biochemical
Analyzer (Hitachi Ltd., Tokyo, Japan). The normal range
of serum SChE was between 4500 and 13,000 IU/L,
using the enzyme velocity method.
In our study, increased SChE activity, defined as
higher than 13,000 IU/L, was observed in 40 % of
children with HFMD caused by EV71 (see Fig. 1a).
The non-parametric Mann–Whitney U test showed
that SChE activity was significantly higher in children
suffering from HFMD caused by EV71 than in
healthy controls (0 % positivity, p < 0.001), as well as
children with URTIs (9.1 % positivity, p = 0.011), BP
(16.3 % positivity, p < 0.001), septicemia (18.5 % posi-
tivity, p < 0.001), amygdalitis (0 % positivity, p < 0.001),
and appendicitis (0 % positivity, p < 0.001). No signifi-
cant differences in SChE activity were observed
among HFMD patients infected with EV71, CVA16
(35.3 % positivity), and PE (41.8 % positivity). In
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addition, higher SChE activity was observed in male
HFMD inpatients (47.7 % positivity) compared to female
inpatients (26.1 % positivity) (Student’s t-test, p < 0.001;
chi-square test, p = 0.002) (see Fig. 1b). Most cases of
HFMD caused by EV71 occurred in children below the
age of two, and particularly in infants under one year of
age (see Fig. 1c). However, we did not observe a significant
difference in elevated SChE levels among different ages
(up to 120 months) (r = -0.112, P > 0.05; see Fig. 1c).
Furthermore, as shown in Fig. 2, after tracking SChE
activity in 19 patients suffering from acute HFMD for
more than two months, we found that serum SChE activ-
ity declined during the recovery phase compared to the
acute phase of the disease (p < 0.001).
Cholinesterase consists of two members, i.e., acetyl-
cholinesterase (AChE) and SChE [15]. Acetylcholin-
esterase is mainly found in erythrocytes, and in the
central and peripheral nervous systems. Its main role
is to catalyze the hydrolysis of the neurotransmitter
acetylcholine into choline and acetic acid, a termin-
ation process necessary for neuronal transmission
after activation. In contrast to AChE, SChE—also
known as plasma cholinesterase, but yrylcholinester-
ase, or acetylcholine acylhydrolase—is synthesized
primarily in the liver and distributed to circulating
fluids. Serum cholinesterase serves mostly as a non-
specific esterase to cleave various esters, even those
with bulkier acyl moieties [16]. Recently, SChE has
been reported as a potential biomarker [17] for solid
CNS tumors [18], chronic heart failure [19], liver
cirrhosis [20, 21], parasympathetic dysfunction, and
inflammation-related diseases [22], although the
underlying mechanisms have yet not been clearly
identified. To our knowledge, its potential value to
diagnose neurotropic virus infections, such as EV71-
associated HFMD, is currently unclear.
Fig. 1 Characteristics of SChE activity in inpatient children infected with HFMD caused by EV71. a SChE activity in 220 inpatient children infected
with HFMD caused by EV71, 34 patients infected with CVA16, and 43 patients infected with PE was compared with SChE activity in healthy children
(n = 80) and HFMD-negative children diagnosed with other common diseases including URTIs (n = 11), BP (n = 43), septicemia (n = 27), amygdalitis
(n = 7), and appendicitis (n = 18). b Higher SChE activity was observed in inpatient males infected with HFMD caused by EV71 compared to female
inpatients. c No significant differences were observed in elevated SChE levels among EV71-infected patients of different ages
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Our study had some limitations. Because the major-
ity of the inpatient children suffering from HFMD
that we studied were infected with EV71, our study
failed to recruit a manageable number of patients in-
fected with other enterovirus serotypes or other infec-
tious diseases. Our study may indicate that higher
SChE activity in HFMD inpatient children is not an
EV71-specific phenomenon, but is also present in
HFMD patients infected with other enteroviruses.
This phenomenon should be verified in a study with
a much larger cohort of non-EV71-infected HFMD
patients. Also, it should be further analyzed if CNS
symptoms complicated with HFMD caused by EV71
are associated with higher SChE activity.
Despite these limitations, our study is the first to re-
port that SChE activity in peripheral blood is higher in
HFMD children than in children diagnosed with other
common diseases and healthy children. This clearly
demonstrates that SChE activity can be used as a po-
tential assistant biomarker for identifying children suf-
fering from HFMD caused by EV71.
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